SIRT1 and Alzheimer disease: In the present study, AD-Tg mice had significantly increased SIRT1 immunoreactivity compared to non-transgenic (NTG) mice that NMN treatment reduced (Figure 4) potentially preserving overall NAD+ pools for functional mitochondrial energetics.